10-114972233-G-A
Variant summary
Our verdict is Likely benign. Variant got -2 ACMG points: 2P and 4B. PM2BP4_Strong
The NM_139169.5(TRUB1):c.695G>A(p.Ser232Asn) variant causes a missense change involving the alteration of a non-conserved nucleotide. The variant allele was found at a frequency of 0.0000478 in 1,609,256 control chromosomes in the GnomAD database, including 1 homozygotes. In-silico tool predicts a benign outcome for this variant. 14/21 in silico tools predict a benign outcome for this variant. Variant has been reported in ClinVar as Uncertain significance (★).
Frequency
Consequence
NM_139169.5 missense
Scores
Clinical Significance
Conservation
Genome browser will be placed here
ACMG classification
Verdict is Likely_benign. Variant got -2 ACMG points.
Transcripts
RefSeq
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | MANE | Protein | UniProt |
---|---|---|---|---|---|---|---|---|
TRUB1 | NM_139169.5 | c.695G>A | p.Ser232Asn | missense_variant | 6/8 | ENST00000298746.5 | NP_631908.1 |
Ensembl
Gene | Transcript | HGVSc | HGVSp | Effect | #exon/exons | TSL | MANE | Protein | Appris | UniProt |
---|---|---|---|---|---|---|---|---|---|---|
TRUB1 | ENST00000298746.5 | c.695G>A | p.Ser232Asn | missense_variant | 6/8 | 1 | NM_139169.5 | ENSP00000298746 | P1 |
Frequencies
GnomAD3 genomes AF: 0.00000657 AC: 1AN: 152158Hom.: 0 Cov.: 32
GnomAD3 exomes AF: 0.000113 AC: 28AN: 246806Hom.: 0 AF XY: 0.000143 AC XY: 19AN XY: 133294
GnomAD4 exome AF: 0.0000522 AC: 76AN: 1456980Hom.: 1 Cov.: 31 AF XY: 0.0000773 AC XY: 56AN XY: 724540
GnomAD4 genome AF: 0.00000657 AC: 1AN: 152276Hom.: 0 Cov.: 32 AF XY: 0.0000134 AC XY: 1AN XY: 74462
ClinVar
Submissions by phenotype
not specified Uncertain:1
Uncertain significance, criteria provided, single submitter | clinical testing | Ambry Genetics | Nov 22, 2022 | The c.695G>A (p.S232N) alteration is located in exon 6 (coding exon 6) of the TRUB1 gene. This alteration results from a G to A substitution at nucleotide position 695, causing the serine (S) at amino acid position 232 to be replaced by an asparagine (N). Based on insufficient or conflicting evidence, the clinical significance of this alteration remains unclear. - |
Computational scores
Source:
Splicing
Find out detailed SpliceAI scores and Pangolin per-transcript scores at